Stock Region Penny Picks
Your daily dose of market movers, breakthroughs, and opportunities!
Stock Region Watchlist Newsletter - Tuesday, June 24, 2025
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: This newsletter is for informational purposes only and should not be considered financial advice. Always do your own research and consult with a financial advisor before making investment decisions. Stocks mentioned here may carry risks, and past performance is not indicative of future results.
Hello, Stock Region family!
It’s been a whirlwind of a day in the markets, and we’ve got some exciting updates to share. From groundbreaking medical advancements to strategic partnerships and regulatory wins, today’s watchlist is packed with potential. Let’s dive in!
$IMUX - Immunic
“A breakthrough for MS patients?”
Immunic has reported positive long-term data from its Phase 2 EMPhASIS trial of Vidofludimus Calcium for relapsing-remitting multiple sclerosis. This is a big deal for the MS community, as it could mean a new, effective treatment option is on the horizon. The stock is currently trading at $0.7644, and while it’s a penny stock, the science behind it is worth keeping an eye on. Could this be the start of something big?
$INM - InMed
“A glimmer of hope for Alzheimer’s?”
InMed’s INM-901 has shown it can significantly reduce neuroinflammation in Alzheimer’s disease during an ex vivo study. While it’s still early days, this news is a beacon of hope in the fight against one of the most devastating diseases of our time. If you’re into biotech plays, this one might be worth a closer look.
$AIMD - Ainos
“AI meets scent intelligence—yes, really!”
Ainos and Kenmec are teaming up to deploy AI-powered scent intelligence in smart factories across Asia. This partnership is as futuristic as it sounds, and it could revolutionize how factories operate. The potential applications are endless, and this is one to watch if you’re into cutting-edge tech.
$TRIB - Trinity Biotech
“Regulatory win sparks transformation!”
Trinity Biotech has secured a key regulatory approval for its rapid HIV test, which will now be manufactured offshore. This move is expected to accelerate both strategic and financial performance. It’s a bold step forward for the company, and investors seem to be taking notice.
$VERU - Veru
“Weight loss without the regain?”
Veru’s Phase 2b QUALITY study has shown that Enobosarm can reduce body weight regain, prevent fat regain, and preserve lean mass after semaglutide discontinuation. This could be a game-changer in the weight-loss market, and the science behind it is fascinating. Keep this one on your radar!
$ONMD - OneMedNet
“Funding secured!”
OneMedNet has announced an additional $3.7M in funding through private placement transactions. With shares priced at $0.42, this funding could provide the boost the company needs to scale its operations. It’s always exciting to see companies secure the resources to grow.
$ASNS - Actelis
“Next-gen connectivity is here!”
Actelis has secured an order from a major US telecommunications carrier for its next-gen rapid MDU connectivity solutions. Trading at $0.66, this stock could be a hidden gem in the tech space.
$ONFO - Onfolio Holdings
“Dividends, anyone?”
Onfolio Holdings has announced a quarterly preferred stock cash dividend of $0.75 per share. With the stock trading at $1.11, this is a solid yield for dividend hunters.
$NSPR - InspireMD
“FDA approval alert!”
InspireMD has received FDA approval for its CGuard® Prime Carotid Stent System, designed to prevent strokes. This is a huge milestone for the company and could open doors to significant market opportunities.
$LFWD - ReWalk Robotics
“A win for accessibility!”
An administrative law judge has determined that the ReWalk Personal Exoskeleton is “reasonable and necessary” for Medicare beneficiaries. This is a major step forward for the company and for individuals who rely on this life-changing technology.
Today’s watchlist is a testament to the power of innovation and strategic thinking. From biotech breakthroughs to AI-powered solutions, these companies are pushing boundaries and creating opportunities. As always, tread carefully, do your research, and invest wisely.
That’s it for today, Stock Region fam! Which of these stocks are you most excited about? Let us know, and as always, happy investing!
Disclaimer: The information provided in this newsletter is not financial advice. Stock Region and its affiliates are not responsible for any investment decisions made based on this content. Always consult with a financial advisor.